In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli
- PMID: 34070637
- PMCID: PMC8229198
- DOI: 10.3390/antibiotics10060632
In Silico Prediction and Prioritization of Novel Selective Antimicrobial Drug Targets in Escherichia coli
Abstract
Novel antimicrobials interfering with pathogen-specific targets can minimize the risk of perturbations of the gut microbiota (dysbiosis) during therapy. We employed an in silico approach to identify essential proteins in Escherichia coli that are either absent or have low sequence identity in seven beneficial taxa of the gut microbiota: Faecalibacterium, Prevotella, Ruminococcus, Bacteroides, Lactobacillus, Lachnospiraceae and Bifidobacterium. We identified 36 essential proteins that are present in hyper-virulent E. coli ST131 and have low similarity (bitscore < 50 or identity < 30% and alignment length < 25%) to proteins in mammalian hosts and beneficial taxa. Of these, 35 are also present in Klebsiella pneumoniae. None of the proteins are targets of clinically used antibiotics, and 3D structure is available for 23 of them. Four proteins (LptD, LptE, LolB and BamD) are easily accessible as drug targets due to their location in the outer membrane, especially LptD, which contains extracellular domains. Our results indicate that it may be possible to selectively interfere with essential biological processes in Enterobacteriaceae that are absent or mediated by unrelated proteins in beneficial taxa residing in the gut. The identified targets can be used to discover antimicrobial drugs effective against these opportunistic pathogens with a decreased risk of causing dysbiosis.
Keywords: Escherichia coli; antimicrobial targets; in silico; microbiota.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures


Similar articles
-
Non-pathogenic Escherichia coli acquires virulence by mutating a growth-essential LPS transporter.PLoS Pathog. 2020 Apr 23;16(4):e1008469. doi: 10.1371/journal.ppat.1008469. eCollection 2020 Apr. PLoS Pathog. 2020. PMID: 32324807 Free PMC article.
-
Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk.J Microbiol Biotechnol. 2016 Oct 28;26(10):1723-1735. doi: 10.4014/jmb.1603.03057. J Microbiol Biotechnol. 2016. PMID: 27381339
-
A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumonia strain PittNDM01.Microb Pathog. 2020 Sep;146:104245. doi: 10.1016/j.micpath.2020.104245. Epub 2020 May 11. Microb Pathog. 2020. PMID: 32423883
-
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?Diseases. 2019 Nov 12;7(4):58. doi: 10.3390/diseases7040058. Diseases. 2019. PMID: 31726747 Free PMC article. Review.
-
Effects of Antibiotic Treatment on Gut Microbiota and How to Overcome Its Negative Impacts on Human Health.ACS Infect Dis. 2020 Oct 9;6(10):2544-2559. doi: 10.1021/acsinfecdis.0c00036. Epub 2020 Sep 2. ACS Infect Dis. 2020. PMID: 32786282 Review.
Cited by
-
Impact of the Gram-Negative-Selective Inhibitor MAC13243 on In Vitro Simulated Gut Microbiota.Pharmaceuticals (Basel). 2022 Jun 9;15(6):731. doi: 10.3390/ph15060731. Pharmaceuticals (Basel). 2022. PMID: 35745650 Free PMC article.
-
Global quantitative proteome analysis of a multi-resistant Klebsiella pneumoniae strain.Front Microbiol. 2025 May 19;16:1528869. doi: 10.3389/fmicb.2025.1528869. eCollection 2025. Front Microbiol. 2025. PMID: 40458706 Free PMC article.
-
LptD depletion disrupts morphological homeostasis and upregulates carbohydrate metabolism in Escherichia coli.FEMS Microbes. 2023 Aug 10;4:xtad013. doi: 10.1093/femsmc/xtad013. eCollection 2023. FEMS Microbes. 2023. PMID: 37701421 Free PMC article.
-
RpoS and the bacterial general stress response.Microbiol Mol Biol Rev. 2024 Mar 27;88(1):e0015122. doi: 10.1128/mmbr.00151-22. Epub 2024 Feb 27. Microbiol Mol Biol Rev. 2024. PMID: 38411096 Free PMC article. Review.
-
Ehretia Species Phytoconstituents as Potential Lead Compounds against Klebsiella pneumoniae Carbapenemase: A Computational Approach.Biomed Res Int. 2023 Oct 12;2023:8022356. doi: 10.1155/2023/8022356. eCollection 2023. Biomed Res Int. 2023. PMID: 37869630 Free PMC article.
References
-
- World Health Organization World Health Organization Releases Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. [(accessed on 24 May 2021)]; Available online: https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-E...
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases